Document Detail


The Mikamo lecture. Tomographic assessment of myocardial perfusion and metabolism in the evaluation of coronary thrombolysis.
MedLine Citation:
PMID:  3108555     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Although coronary thrombolysis with fibrinolytic agents leads to restoration of patency of coronary arteries demonstratable angiographically, elucidation of the efficacy of the approach requires evaluation of its effect on the heart. Clot-selective fibrinolytic agents such as tissue-type plasminogen activator (t-PA) offer particular promise as therapeutic agents because they induce clot lysis without marked activation of the fibrinolytic system in the circulating blood and hence without marked fibrinogenolysis and predisposition to bleeding. Results of several large scale clinical trials demonstrate recanalization in approximately 75% of patients. Detection of recanalization may be achievable by analysis of plasma creatine kinase isoforms as a function of time, and in the research environment, with the use of positron emission tomography. This modality demonstrates restoration of regional perfusion and intermediary myocardial metabolism and provides an approach for calibration of conventional and more widely applicable diagnostic procedures such as scintigraphy.
Authors:
B E Sobel
Related Documents :
11922645 - Clinical characteristics and outcome of patients with early (<2 h), intermediate (2-4 h...
7479465 - The management of acute myocardial infarction.
16394615 - Predicting no-reflow based on angiographic features of lesions in patients with acute m...
8017295 - Frequency of achieving optimal reperfusion with thrombolysis in acute myocardial infarc...
2714915 - First passage radionuclide cardiography for determination of cardiac output: evaluation...
9926275 - Combination of a calcium antagonist, verapamil, with an angiotensin converting enzyme i...
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Japanese circulation journal     Volume:  51     ISSN:  0047-1828     ISO Abbreviation:  Jpn. Circ. J.     Publication Date:  1987 Jan 
Date Detail:
Created Date:  1987-07-08     Completed Date:  1987-07-08     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  7806868     Medline TA:  Jpn Circ J     Country:  JAPAN    
Other Details:
Languages:  eng     Pagination:  1-4     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Chemotherapy, Cancer, Regional Perfusion
Coronary Angiography
Coronary Circulation
Coronary Disease / drug therapy*
Fibrinolytic Agents / therapeutic use*
Humans
Tissue Plasminogen Activator / therapeutic use
Tomography, Emission-Computed
Grant Support
ID/Acronym/Agency:
HL 17646/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Fibrinolytic Agents; EC 3.4.21.68/Tissue Plasminogen Activator

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Parenteral nutrition-associated cholestasis: recovery following phenobarbitone.
Next Document:  A case report of hyperlipemia with giant fatty liver during adjuvant endocrine therapy by tamoxifen